Toronto-Dominion Bank vs Tempus AI — how do they compare? Toronto-Dominion Bank trades at $120.27 (market cap $197.03B), while Tempus AI trades at $49.03 (market cap $8.69B). The key difference: Toronto-Dominion Bank is far larger — about 22.7× Tempus AI's market cap, and Toronto-Dominion Bank pays a 2.62% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| TD | TEM | |
|---|---|---|
Market Cap | $197.03B | $8.69B |
Sector | Financials | Broad Market / Factor |
52-Week High | $124.80 | $103.25 |
52-Week Low | $72.55 | $42.37 |
Dividend Yield | 2.62% | — |
Enterprise Value | — | $9.37B |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tempus AI (TEM) trades at $48.41, down 7.74% in the last 24 hours, reflecting a bearish technical signal. The company reported revenue of $1.27 billion in 2025 but a net loss of $245.03 million, with negative profitability metrics. Recent news highlights growth in AI-driven diagnostics and data services, including FDA approvals and research collaborations. The stock is trading well below the analyst consensus price target of $68.50, with a majority of analysts maintaining a Buy rating.
The outlook for TEM is a mix of high growth potential in healthcare AI and significant financial risk due to persistent losses. Investment opportunity lies in its proprietary data platform and expanding market reach, but risks include execution challenges and cash burn. Wall Street sentiment remains positive on long-term prospects, but investors should weigh the volatility against the company's unproven path to profitability.
Trailing returns across standard periods
Latest headlines on both assets
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →